(Q40710832)

23 September 2017

Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus (English)

1 reference

23 September 2017

Staphylococcus aureus

1 reference

Quickel KE Jr

1

1 reference

23 September 2017

Selden R

2

1 reference

23 September 2017

Caldwell JR

3

1 reference

23 September 2017

Nora NF

4

1 reference

23 September 2017

Schaffner W

5

1 reference

23 September 2017

1 September 1971

1 reference

23 September 2017

1 reference

23 September 2017

22

1 reference

23 September 2017

3

1 reference

23 September 2017

446-450

1 reference

LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS

23 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Antibiotic susceptibility testing by a standardized single disk method

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

Comparative Inhibition of Methicillin-resistant Strains of Staphylococcus aureus by Lysostaphin and Otner Antibiotics

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

The reacquisition of staphylococci by treated carriers: a demonstration of bacterial interference

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=376330

The selective activity of lysostaphin in vivo

19 August 2018

1 reference

12 December 2020

Effect of lysostaphin on staphylococcal carriage in infants and children

1 reference

12 December 2020

Studies in experimental staphylococcal endocarditis in dogs. VI. Treatment with lysostaphin

1 reference

12 December 2020

LYSOSTAPHIN: ENZYMATIC MODE OF ACTION

1 reference

12 December 2020

PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS

1 reference

12 December 2020

Identifiers

1 reference

23 September 2017

PubMed publication ID

4330318

1 reference